ERNA
Eterna Therapeutics IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$5.89M
P/E Ratio
—
EPS
$-2.30
Beta
6.85
52W High
$4.05
52W Low
$0.18
50-Day MA
$0.32
200-Day MA
$1.17
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Eterna Therapeutics Inc
Brooklyn ImmunoTherapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to developing therapies to treat cancer patients. The company is headquartered in Brooklyn, New York.
Fundamentals
| Revenue (TTM) | 1,000 |
| Gross Profit (TTM) | 1,000 |
| EBITDA | $-9.25M |
| Operating Margin | 0.00% |
| Return on Equity | -687.00% |
| Return on Assets | -104.90% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.31 |
| Price-to-Book | 2.39 |
| Price-to-Sales (TTM) | 1275.37 |
| EV/Revenue | 4581.99 |
| EV/EBITDA | -0.29 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -94.10% |
| Shares Outstanding | $29.15M |
| Float | $20.45M |
| % Insiders | 41.78% |
| % Institutions | 1.79% |
Data last updated: 4/15/2026